Henry Schein Inc. (HSIC) Downgraded by Robert W. Baird
Henry Schein Inc. (NASDAQ:HSIC) was downgraded by equities researchers at Robert W. Baird from an “outperform” rating to a “neutral” rating in a report released on Friday. They presently have a $164.00 price objective on the stock, down from their prior price objective of $176.00. Robert W. Baird’s target price suggests a potential upside of 5.09% from the stock’s current price.
Several other research firms also recently weighed in on HSIC. Zacks Investment Research downgraded shares of Henry Schein from a “hold” rating to a “sell” rating in a research report on Monday, August 8th. Bank of America Corp. initiated coverage on shares of Henry Schein in a research report on Monday, September 12th. They set a “buy” rating and a $185.00 price target for the company. Finally, Goldman Sachs Group Inc. upgraded shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $185.00 price target for the company in a research report on Tuesday. Seven investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $159.50.
Henry Schein (NASDAQ:HSIC) opened at 156.05 on Friday. The stock has a market cap of $12.76 billion, a price-to-earnings ratio of 26.44 and a beta of 1.05. Henry Schein has a 12 month low of $142.64 and a 12 month high of $183.00. The firm’s 50 day moving average price is $162.38 and its 200 day moving average price is $170.17.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/14/henry-schein-inc-hsic-downgraded-by-robert-w-baird.html
Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Thursday, August 4th. The company reported $1.64 earnings per share for the quarter, topping the consensus estimate of $1.63 by $0.01. Henry Schein had a net margin of 4.42% and a return on equity of 17.84%. The firm earned $2.87 billion during the quarter, compared to the consensus estimate of $2.85 billion. During the same quarter in the prior year, the firm earned $1.46 EPS. The company’s revenue for the quarter was up 9.3% on a year-over-year basis. On average, equities research analysts predict that Henry Schein will post $6.57 EPS for the current fiscal year.
In other news, Director Paul Brons sold 3,381 shares of the firm’s stock in a transaction that occurred on Monday, August 29th. The shares were sold at an average price of $164.03, for a total transaction of $554,585.43. Following the completion of the sale, the director now owns 13,715 shares in the company, valued at approximately $2,249,671.45. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.27% of the company’s stock.
Several hedge funds have recently made changes to their positions in HSIC. Artemis Investment Management LLP boosted its position in Henry Schein by 97.5% in the second quarter. Artemis Investment Management LLP now owns 111,236 shares of the company’s stock worth $19,666,000 after buying an additional 54,920 shares during the last quarter. Bank of Montreal Can bought a new position in Henry Schein during the second quarter worth $32,344,000. Zurich Insurance Group Ltd FI bought a new position in Henry Schein during the first quarter worth $3,204,000. Meiji Yasuda Asset Management Co Ltd. boosted its position in Henry Schein by 60.0% in the first quarter. Meiji Yasuda Asset Management Co Ltd. now owns 2,586 shares of the company’s stock worth $446,000 after buying an additional 970 shares during the last quarter. Finally, Eqis Capital Management Inc. boosted its position in Henry Schein by 23.4% in the second quarter. Eqis Capital Management Inc. now owns 1,639 shares of the company’s stock worth $290,000 after buying an additional 311 shares during the last quarter. Institutional investors and hedge funds own 91.98% of the company’s stock.
About Henry Schein
Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.